Gadolinium

 

Gadolinium Risks

Gadolinium is used in contrast agents for MRIs and may cause NSF.Gadolinium-based contrast agents, typically used in MRI exams, have recently been linked to a disease known as NSF or nephrogenic systemic fibrosis. This destructive disease, for which there is no known cure or treatment, causes the skin and connective tissue to thicken, affecting the ability to move, and increasing the risk of bone fractures. In a recent report issued by the FDA, it was noted that this type of contrast material is favored particularly in patients with chronic kidney disease, and can produce this serious ailment after even only a single injection of the gadolinium agents. The FDA has identified the following gadolinium agents and their respective manufacturers: gadopentetate dimeglumine or Magnevist (Bayer Schering Pharama); gadodiamide, Ominiscan (GE Healthcare); gadoversetamide or Optimark (Mallinckrodt, Inc.); gadobenate dimeglumine or MultiHance and gadoteridol, ProHance by Bracco Diagnostics Inc.

 

 









Ashkin Law Firm
Roberta Ashkin, Esq.
300 East 42nd St. 14th Fl
New York New York 10017
Telephone: (646) 779 8520
Facsimile: (212) 593 9997
» click here to locate our office